Publications by authors named "Maureen Lane"

Claim this Profile
C
Correction: Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases.
Nancy Chan, Amy Willis, Naomi Kornhauser, Maureen M Ward, Sharrell B Lee, Maureen E Lane

Clin Cancer Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases.
Nancy Chan, Amy Willis, Naomi Kornhauser, Maureen M Ward, Sharrell B Lee, Maureen E Lane

Clin Cancer Res· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways.
Peter DelNero, Maureen Lane, Scott S Verbridge, Brian Kwee, Pouneh Kermani

Biomaterials· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity.
Sasha E Stanton, Maureen M Ward, Paul Christos, Rachel Sanford, Christina Lam, Maureen E Lane

BMC Cancer· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients.
Gigi J Ebenezer, Karen Carlson, Diana Donovan, Marta Cobham, Ellen Chuang, Maureen E Lane

Ann Clin Transl Neurol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach.
Allyson J Ocean, Paul Christos, Joseph A Sparano, Manish A Shah, Rhonda K Yantiss, Maureen E Lane

Invest New Drugs· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization.
Ruben Niesvizky, Tomer M Mark, Maureen Ward, David S Jayabalan, Roger N Pearse, Maureen E Lane

Clin Cancer Res· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.
Sarika Jain, Maureen M Ward, Jennifer O'Loughlin, Marissa Boeck, Naomi Wiener, Maureen E Lane

Breast Cancer Res Treat· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer.
Allyson J Ocean, Paul Christos, Joseph A Sparano, Dan Matulich, Andreas Kaubish, Maureen E Lane

Cancer Chemother Pharmacol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II proof-of-concept study of pazopanib monotherapy in treatment-naive patients with stage I/II resectable non-small-cell lung cancer.
Nasser Altorki, Maureen E Lane, Thomas Bauer, Paul C Lee, Michael J Guarino

J Clin Oncol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung biopsy: special techniques.
Matthew D Cham, Maureen E Lane, Claudia I Henschke, David F Yankelevitz

Semin Respir Crit Care Med· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical applications of p53-directed gene therapy.
Scott Wadler, Della Makower, Bo Yu, Jian-You Tan, Alla Rozenblit, Maureen E Lane

Suppl Tumori· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.
Della Makower, Alla Rozenblit, Howard Kaufman, Morris Edelman, Maureen E Lane

Clin Cancer Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants.
Scott Wadler, Bo Yu, Jian-You Tan, Ron Kaleya, Alla Rozenblit, Maureen Lane

Clin Cancer Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells.
Bo Yu, Maureen E Lane, Scott Wadler

Biochem Pharmacol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis